Hepatitis - References

Highlights	Hepatitis B and D	Outlook
Introduction	Hepatitis C	Resources
Diagnosis	Autoimmune Hepatitis	References
Hepatitis A	Symptom Management

References

Centers for Disease Control and Prevention. Incidence of Acute Hepatitis B: United States, 1990-2002. MMWR. 2004; 52:1252-1254.

Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, et al. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone. Ann Intern Med. 2005;142(4):240-250.

Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet. 2005;365(9454):123-129.

text continues below

Lok AS, McMahon BJ, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology. 2004;39(3):857-861.

Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, et al. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med. 2005;142(2):105-114.

Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology. 2004;39(2):476-483.